Award recordCONTRACT

TAKEDA PHARMACEUTICALS AMERICA, INC.

PIID 36C26124N0744· VHA· 261-NETWORK CONTRACT OFFICE 21 (36C261)· 6505 · DRUGS AND BIOLOGICALS· FY2024· $69,784 net obligations· UEI ENNFDLWFC6L1· MA

Description

PONATINIB

First action · last action
2024-07-01 · 2025-04-09
Transactions
2
First transaction's obligation
$83,740
Base + all options value (sum of deltas)
$69,784
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
1
SDVOSB flag on record
No
Parent IDV
36F79718D0586
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 2 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$83,740$0Base award · 2024-07-01 · this action $83,740 · running total $83,740Modification P00001 · 2025-04-09 · this action -$13,957 · running total $69,784
  • Base2024-07-01+$83,740= $83,740
  • Mod P000012025-04-09-$13,957= $69,784
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2024-07-01+$83,740$83,740PONATINIB
Mod P00001· CLOSE OUT2025-04-09−$13,957$69,784PONATINIB

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI ENNFDLWFC6L1)

AwardOffice · PSC / listingNet obligationsFY
36C24526N0839245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$38,360FY2026
36C24526N0825245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$38,098FY2026
36C24526N0787245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$38,098FY2026
36C24526N0772245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$34,605FY2026
36C24526N0758245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$38,098FY2026
36C24526N0712245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$14,386FY2026

Other recipients under 6505 from 261-NETWORK CONTRACT OFFICE 21 (36C261) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C26126P1178OPTUM FRONTIER THERAPIES II, LLC261-NETWORK CONTRACT OFFICE 21 (36C261)$58,374FY2026
36C26126P1102ENVIGO RMS LLC261-NETWORK CONTRACT OFFICE 21 (36C261)$74,586FY2026
36C26126P096110X GENOMICS, INC.261-NETWORK CONTRACT OFFICE 21 (36C261)$34,600FY2026
36C26126P0997SIERRA RADIOPHARMACY LLC261-NETWORK CONTRACT OFFICE 21 (36C261)$247,204FY2026
36C26126P1008OPTUM FRONTIER THERAPIES II, LLC261-NETWORK CONTRACT OFFICE 21 (36C261)$58,374FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C26124N0744_3600_36F79718D0586_3600 · retrieved 2026-09-26.